China NMPA announces the issuance of Technical Review Guidance for the Registration of Neonatal Phototherapy Device on December 28, 2021. The Guidance aims to guide and standardize the registration for all neonatal phototherapy devices in China. Avalon was honored to be invited to participate the drafting of the Guidance since 2020 by the Guangdong Provincial Medical Products Administration (GDMPA).

KangaLite is designed to make the treatment of neonatal jaundice at home possible. It is a wearable phototherapy device which promotes kangaroo care as well as breast-feeding. More importantly, KangaLite offers an ideal option for home phototherapy during COVID-19 pandemic.